{"id":57490,"date":"2020-07-23T03:01:55","date_gmt":"2020-07-23T01:01:55","guid":{"rendered":"https:\/\/www.csregypt.com\/?p=57490"},"modified":"2020-07-23T03:01:55","modified_gmt":"2020-07-23T01:01:55","slug":"pfizer-gets-1-95-bn-to-produce-coronavirus-vaccine-by-years-end","status":"publish","type":"post","link":"https:\/\/csregypt.com\/en\/pfizer-gets-1-95-bn-to-produce-coronavirus-vaccine-by-years-end\/","title":{"rendered":"Pfizer gets $1.95 bn to produce coronavirus vaccine by year\u2019s end"},"content":{"rendered":"
\n
\n

As nations around the world race to lock up coronavirus vaccines<\/a>\u00a0even before they are ready, the Trump administration on Wednesday made one of the largest investments yet, announcing a nearly $2 billion contract with Pfizer and a German biotechnology company for 100 million doses by December.<\/p>\n

The contract is part of what the White House calls the Warp Speed project, an effort to drastically shorten the time it would take to manufacture and distribute a working\u00a0vaccine<\/a>. So far, the United States has put money into more than a half dozen efforts, hoping to build manufacturing ability for an eventual breakthrough.<\/p>\n

Europe has a parallel effort underway. Germany recently took a 23 percent stake in a German firm, CureVac, that\u00a0President Trump once tried to lure<\/a>\u00a0to American shores in hopes that its vaccine, if successful, would be distributed in the United States first.<\/p>\n

A\u00a0European-led fund-raising effort in May<\/a>\u00a0brought $8 billion in pledges from the world\u2019s governments, philanthropists and leaders for coronavirus vaccine research, even with the United States sitting out the conference.<\/p>\n

China, meantime, has militarized the effort: Researchers associated with the Academy of Military Medical Sciences have developed one of China\u2019s leading vaccine candidates, and another Chinese firm, Sinopharm Group, announced in June that it was beginning Phase 3 trials in the United Arab Emirates.<\/p>\n<\/div>\n